Page 6,397«..1020..6,3966,3976,3986,399..6,4106,420..»

Sinai Hospital Opens New Neurological Rehabilitation Center

Posted: Published on October 12th, 2012

Newswise Baltimore, Md. - Sinai Hospital of Baltimore announces the opening of the new Louis and Phyllis Friedman Neurological Rehabilitation Center. The 20-bed center located on the fifth floor of the hospitals South Tower provides specialized rehabilitation services to adults who have sustained a brain injury, stroke or other neurological disorder and is one of the most advanced facilities of its kind in the state. The center offers a comprehensive, patient-centered approach to treatment, featuring the latest technology; a team of more than 40 doctors, nurses and therapists; and an emphasis on family-centered care. Highlights include: A dedicated nine-bed brain injury unit with the highest number of certified brain injury specialists in Maryland A state-of-the-art gym filled with the most advanced technology to assist patients in their daily therapy, including a ZeroG gait and balance training system, an advanced tool that enables therapists to safely treat patients through a wide range of activities, and the latest generation of training devices for visual perception A simulated community called "Greater Heights" that helps facilitate patients integration into their own community following discharge, featuring grocery store and bus stop settings and an ATM A fully equipped home transition apartment that allows patients to … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Sinai Hospital Opens New Neurological Rehabilitation Center

NASCAR: The Anatomy of a Concussion

Posted: Published on October 12th, 2012

A concussion is a type of traumatic brain injury, or TBI, caused by a bump, blow, or jolt to the head that can change the way your brain normally works. After the original blow, the brain then hits the skull in a counterblow that causes the head and brain to move quickly back and forth. In more severe cases, often as the result of twisting the neck during the blow, pressure is put on the brain stem. This is particularly worrisome, as the brain stem is where all basic involuntary life functions are controlled including heart rate, breathing, sleeping and eating. Bleeding, or other damage may occur as a result of a concussion. Often, people who sustain a concussion cannot remember the events surrounding the blow. Symptoms of a concussion include being drowsy, hard to wake up or similar changes, having a headache, loss of consciousness, memory loss (amnesia) of events before the injury or right after, nausea and vomiting, seeing flashing lights, or even feeling like you have "lost time". Sometimes the symptoms may even be severe enough to seek immediate medical attention. According to the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine … Continue reading →

Posted in Brain Injury Treatment | Comments Off on NASCAR: The Anatomy of a Concussion

Traumatic Brain Injury in Kids and Teens Can Impact School Performance

Posted: Published on October 12th, 2012

Fall Sports Season Signals Parents to Watch for Symptoms and Engage School-Based Speech-Language Pathologists to Help Rockville, MD (PRWEB) October 11, 2012 Kids and teens suffering from TBI may struggle with speech, language, and thinking, which can lead to problems reading or memorizing. They may have more trouble than usual focusing on tasks and homework or difficulties paying attention in class. Poor grades and/or problems talking with friends or doing favorite activities may result. Every school district across the United States has a speech-language pathologist (SLP) who can work with a TBI-impacted student and his or her family and teachers to create a treatment plan. Leveraging their training in cognitive communication impairments and experience helping children develop language and reading skills, SLPs can administer and interpret cognitive and behavioral assessments. They may also work with teachers to transition kids returning to school after TBI and modify test times, class loads, homework, and deadlines as needed. Having ongoing access to school-based SLPs can be especially helpful, given that the full impact of a brain injury may not be evident until months or even years later. A child who has a TBI in kindergarten may not have noticeable difficulty in school until … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Traumatic Brain Injury in Kids and Teens Can Impact School Performance

Research and Markets: Key Findings from Treatment Algorithms: Multiple Sclerosis

Posted: Published on October 12th, 2012

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/ts4pv3/key_findings_from) has announced the addition of Decision Resources, Inc's new report "Key Findings from Treatment Algorithms: Multiple Sclerosis" to their offering. Until recently, the MS market comprised a stable mix of time-tested disease-modifying therapies with established roles in treatment several interferon-beta (IFN-) products, glatiramer acetate (Teva's Copaxone), and natalizumab (Biogen Idec/Elan's Tysabri). Today, however, the MS market stands at the brink of transformation. The 2010 launch of fingolimod (Novartis/Mitsubishi Tanabe Pharma's Gilenya)the first orally administered disease-modifying drug for MSmarks the beginning of a new era in MS treatment that will feature enhanced treatment choice, increasingly complex decision-making for prescribers, and an invigorated push toward individualized treatment. In the coming years, neurologists will strive to integrate new therapeutic options with unique risk/benefits into an ingrained treatment paradigm that favors long-term safety and clinical experienceeven at the expense of more-robust efficacy. Key Topics Covered: 1. Background a) Publication Update b) Report Contents and Features c) Current Practice Guidelines See the original post here: Research and Markets: Key Findings from Treatment Algorithms: Multiple Sclerosis … Continue reading →

Posted in MS Treatment | Comments Off on Research and Markets: Key Findings from Treatment Algorithms: Multiple Sclerosis

TYSABRI® (natalizumab) Data at ECTRIMS Reaffirm Positive Effects of Treatment for People with Relapsing Forms of MS

Posted: Published on October 12th, 2012

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)-- Today, Biogen Idec (BIIB) and Elan Corporation, plc (ELN) announced that results from 11 company-sponsored TYSABRI presentations, including 10 posters and one platform, will be available for viewing at the 28TH Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10 13. Key data highlights from ECTRIMS include: These data further establish the benefits of TYSABRI in reducing relapse rates and slowing disease progression, said Alfred Sandrock, M.D., Ph.D., senior vice president, Development Sciences and Chief Medical Officer, Biogen Idec. Data from TOP demonstrate that patients who began TYSABRI earlier had better outcomes than patients in the study who were switched to TYSABRI at two years, further demonstrating the positive effect TYSABRI can make for those living with MS. Multiple sclerosis (MS) is an often debilitating disease of the brain and spinal cord that affects nearly 2.1 million people worldwide. While a number of disease modifying therapies are currently available, an unmet need remains for effective treatment options. Common symptoms of MS, such as cognitive difficulties, fatigue and visual function can have a tremendous impact on people living with MS. said Hans Peter Hasler, Chief Operating Officer, … Continue reading →

Posted in MS Treatment | Comments Off on TYSABRI® (natalizumab) Data at ECTRIMS Reaffirm Positive Effects of Treatment for People with Relapsing Forms of MS

New Study Finds Hormone Therapy May Reduce Heart Attack Risk

Posted: Published on October 12th, 2012

October 10, 2012 Lee Rannals for redOrbit.com Your Universe Online According to a study published in the journal BMJ, taking hormone replacement therapy (HRT) may reduce the risk of developing heart problems. The researchers found that HRT is not associated with an increased risk of cancer or stroke as several previous studies have claimed, and it also may help reduce the risk of heart attacks. The team followed 1,000 women over 10 years, half of which were on HRTs. Women who took part in the study were between 45 and 58 years old, and were recently menopausal. HRT had significantly reduced risk of mortality, heart failure, or heart attack, without any apparent increase of cancer, deep vein thrombosis or stroke, the researchers wrote in the journal. However, they cautioned due to the potential time lag, longer time and additional studies may be needed to more accurately assess the potential benefits of HRTs. HRTs are commonly used to replace female hormones that are no longer produced following menopause, and they can help to reduce symptoms of menopause such as hot flashes, insomnia, headaches and irritability. Over 30 women in the group after 10 years had not taken HRT, and had died … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on New Study Finds Hormone Therapy May Reduce Heart Attack Risk

RBCC: Nobel Prize Could Bring Big Investments in Stem Cell Research

Posted: Published on October 12th, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)-- The awarding of the Nobel Prize this week to two scientists who have revolutionized stem cell research could lead to an influx of investment capital into the industry, said Rainbow Coral Corp. (RBCC) CEO Patrick Brown on Wednesday. Japans Shinya Yamanaka and Britain's John Gurdon were jointly awarded the medicine prize for proving that adult cells can be regressed back into stem cells, creating cells known as induced pluripotent stem cells (iPS) that allow for stem-cell research that doesnt necessitate the destruction of a fetus. The tremendous recognition of this groundbreaking research that the Nobel Prize brings could spark a host of medical breakthroughs, investment interest and business developments in the stem cell field, Brown said. Its a very exciting time to be part of a young company striving to grow alongside this explosive industry. Wire service AFP reported this week that Yamanaka will likely get up to 30 billion yen ($383 million) for his stem cell research over the next decade. RBCC is currently working to help speed up the research of Yamanaka and others into potential cures for deadly diseases by commercializing the use of a groundbreaking new technology in select markets around the world. … Continue reading →

Posted in Stem Cell Research | Comments Off on RBCC: Nobel Prize Could Bring Big Investments in Stem Cell Research

Cheap genome sequences demand new rules on privacy

Posted: Published on October 12th, 2012

Peter Aldhous, San Francisco bureau chief In the era of the $1000 human genome, new rules will be needed to protect people's genetic privacy. The US government and individual states should harmonize a mish-mash of laws to ensure a basic "floor" of genetic privacy protection across the nation, however the data information was obtained, the commission adds. For instance, if a volunteer has their genome sequenced for research, the information should have similar protection from prying eyes as if the analysis had been ordered by a doctor for diagnostic purposes. Breaches in security of DNA sequence data held on computer systems are the most obvious threat. But in 2009, New Scientist pointed to another danger by simulating the surreptitious analysis of my genome: a colleague used commercially available services to extract DNA from a glass from which I had drunk, and analyse it for my genetic predispositions to disease. We ordered a scan of about 1 million letters of my genetic code, but plummeting prices and advancing technology will soon make it feasible to obtain a full genome sequence in a similar way, at modest cost. The new report comes down firmly against surreptitious genome sequencing:"[P]olicies should protect individual privacy … Continue reading →

Comments Off on Cheap genome sequences demand new rules on privacy

Citing privacy concerns, U.S. panel urges end to secret DNA testing

Posted: Published on October 12th, 2012

NEW YORK (Reuters) - They're called discreet DNA samples, and the Elk Grove, California, genetic-testing company easyDNA says it can handle many kinds, from toothpicks to tampons. Blood stains from bandages and tampons? Ship them in a paper envelope for paternity, ancestry or health testing. EasyDNA also welcomes cigarette butts (two to four), dental floss ("do not touch the floss with your fingers"), razor clippings, gum, toothpicks, licked stamps and used tissues if the more standard cheek swab or tube of saliva isn't obtainable. If the availability of such services seems like an invitation to mischief or worse - imagine a discarded tissue from a prospective employee being tested to determine whether she's at risk for an expensive disease, for instance - the Presidential Commission for the Study of Bioethical Issues agrees. On Thursday it released a report on privacy concerns triggered by the advent of whole genome sequencing, determining someone's complete DNA make-up. Although sequencing "holds enormous promise for human health and medicine," commission chairwoman Amy Gutmann told reporters on Wednesday, there is a "potential for misuse of this very personal data." "In many states someone can pick up your discarded coffee cup and send it for (DNA) testing," … Continue reading →

Comments Off on Citing privacy concerns, U.S. panel urges end to secret DNA testing

Iverson Genetic Diagnostics, Inc. Announces an Exclusive Licensing Agreement with Johns Hopkins University School of …

Posted: Published on October 12th, 2012

BOTHELL, Wash.--(BUSINESS WIRE)-- Iverson Genetic Diagnostics, Inc. announced today an exclusive licensing agreement with Johns Hopkins University School of Medicine under which Iverson receives global exclusive commercialization rights for molecular diagnostics that are designed to help physicians to assess cardiovascular risk in men and women and infertility risk in women. In this new era of personalized medicine, it is now possible to more accurately determine if the healthy cholesterol fraction, HDL, and its partner protein, scavenger receptor class B type I (SR-BI), affect risk for heart disease in men and women as well as hormonal and fertility outcomes in women. Mutations within the SR-BI gene (SCARB1) are common and work by Annabelle Rodriguez-Oquendo, M.D. at John Hopkins University School of Medicine has suggested that variations within theSCARB1gene show associations with heart disease risk in men and women as well as hormonal and fertility problems in women. Leroy Hood, M.D., Ph.D., co-founder of the Institute for Systems Biology and a member of Iverson Genetic Diagnostics Board of Directors, commented, The importance of finding gene variants that affect the metabolism of cholesterol, especially the healthy fraction, and hormones--hence causing disease--is incredibly important for personalized medicine. This agreement between Iverson and Johns Hopkins … Continue reading →

Comments Off on Iverson Genetic Diagnostics, Inc. Announces an Exclusive Licensing Agreement with Johns Hopkins University School of …

Page 6,397«..1020..6,3966,3976,3986,399..6,4106,420..»